Mendelsohn Alan 4
4 · Timber Pharmaceuticals, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Mendelsohn Alan
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-07-01+347,991→ 347,991 totalExercise: $1.18Exp: 2031-07-01→ Common Stock, par value $0.001 per share (347,991 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.
- [F2]25% of the options vest on July 1, 2022, and the remaining options will vest in 36 equal monthly installments beginning on August 1, 2022 as long as the reporting person remains continuously employed through each vesting date.